| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206. | J Clin Oncol | 2005 | 4.77 |
| 2 | Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer. | Mol Cancer Ther | 2012 | 1.44 |
| 3 | Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma. | Cancer | 2006 | 1.35 |